Zoom has announced that it will be going public on April 18th 2019. This has generated substantial hype and lead to a valuation of $36 per share tomorrow. In this article I will discuss; Potential … [Read more...] about Should You Buy The ZOOM IPO?
https://www.youtube.com/watch?v=4MecjQHamEo&ab_channel=M%26SMoneyMoves … [Read more...] about An Intro to EMA’s When Trading Biotech Stocks
Whats Happening? Novavax Inc. (Nasdaq: NVAX) is getting attention lately as investors debate the potential of the company’s respiratory syncytial virus (RSV) vaccination “ResVax”, a proposed 1:20 … [Read more...] about NVAX At A Glance
You voted and we heard you. After my initial article on a few noteworthy results from AACR 2019, we asked you the subscribers to choose one of the four companies that you would like to learn more … [Read more...] about An In-Depth Assessment Of TG Therapeutics
Background Investors have recently been faced with many headwinds in the first half of 2019. With potential threats to Bulls positions constantly surfacing, 2019 has been volatile to say the least. … [Read more...] about Why I’m Bullish With Brexit
As the Market's overheating, (Nasdaq: LABD) the S&P Biotech Bear 3x hits all-time lows, and Brexit fears loom. LABD gives a nice potential entry for biotech traders looking for protection the next … [Read more...] about Why I’m Bullish On Brexit: Part deux